Clinician-assessed NYHA and EHRA symptom classifications only moderately reflect patient-reported quality of life in heart failure and atrial fibrillation.

IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Netherlands Heart Journal Pub Date : 2026-08-01 Epub Date: 2026-07-06 DOI:10.1007/s12471-026-02051-9
Jeroen A A van de Pol, Frederique J Hafkamp, Pepijn H van der Voort, Johannes C Post, Sylvie F A M S de Jong, Monica Monroy, Sabine C M Eijsbouts, Ruud F Spee, Arjen R T van de Ven, Boudewijn Klop
{"title":"Clinician-assessed NYHA and EHRA symptom classifications only moderately reflect patient-reported quality of life in heart failure and atrial fibrillation.","authors":"Jeroen A A van de Pol, Frederique J Hafkamp, Pepijn H van der Voort, Johannes C Post, Sylvie F A M S de Jong, Monica Monroy, Sabine C M Eijsbouts, Ruud F Spee, Arjen R T van de Ven, Boudewijn Klop","doi":"10.1007/s12471-026-02051-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinician-assessed symptoms are expected to agree with patient-perceived symptoms. However, patients may value the impact of symptoms on their health-related quality of life (HRQoL) differently from clinicians. This study aimed to evaluate the relationship between patient-perceived HRQoL and clinician-assessed symptom severity in patients with Heart Failure (HF) and Atrial Fibrillation (AF).</p><p><strong>Methods: </strong>Newly diagnosed HF and AF patients were prospectively included. Information on symptoms and HRQoL was collected at diagnosis and after 12 months during routine HF- and AF-outpatient clinic visits. Symptom severity was assessed by clinicians using the NYHA classification for HF and EHRA score for AF. HRQoL was assessed using the CaReQol-CHF (HF) and AFEQT (AF).</p><p><strong>Results: </strong>Complete baseline and 12-month follow-up information was available for 254 HF patients and 765 AF patients. Moderate correlations were observed between NYHA classification and CaReQoL-CHF at diagnosis and follow-up (Spearman's ρ: HF<sub>social</sub>: 0.202 and 0.426, HF<sub>physical</sub>: 0.317 and 0.421, respectively), and between EHRA score and AFEQT (Spearman's ρ: -0.363 and -0.305). Clinician-assessed improvement in HF or AF symptoms from diagnosis to 12 months was associated with patient-reported improvement in HRQoL (HF<sub>social</sub>: F(250.2) = 3.11, p < 0.046; HF<sub>physical</sub>: F(251.2) = 11.19, p < 0.001; and AF: F(762.2) = 25.86, p < 0.001). When clinicians reported unchanged or worsening symptoms, no significant HRQoL changes were reported by patients.</p><p><strong>Conclusion: </strong>Clinician-assessed symptoms correlate moderately with patient-reported HRQoL, with large inter-individual variation in HRQoL. NYHA and EHRA classifications may not accurately reflect patient-perceived burden of disease over time. Incorporating patient-reported outcomes into routine care may better guide treatment, improve the identification of patients' needs, and support informed clinical and shared decision-making.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"274-282"},"PeriodicalIF":2.5000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13375993/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Netherlands Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12471-026-02051-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/6 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Clinician-assessed symptoms are expected to agree with patient-perceived symptoms. However, patients may value the impact of symptoms on their health-related quality of life (HRQoL) differently from clinicians. This study aimed to evaluate the relationship between patient-perceived HRQoL and clinician-assessed symptom severity in patients with Heart Failure (HF) and Atrial Fibrillation (AF).

Methods: Newly diagnosed HF and AF patients were prospectively included. Information on symptoms and HRQoL was collected at diagnosis and after 12 months during routine HF- and AF-outpatient clinic visits. Symptom severity was assessed by clinicians using the NYHA classification for HF and EHRA score for AF. HRQoL was assessed using the CaReQol-CHF (HF) and AFEQT (AF).

Results: Complete baseline and 12-month follow-up information was available for 254 HF patients and 765 AF patients. Moderate correlations were observed between NYHA classification and CaReQoL-CHF at diagnosis and follow-up (Spearman's ρ: HFsocial: 0.202 and 0.426, HFphysical: 0.317 and 0.421, respectively), and between EHRA score and AFEQT (Spearman's ρ: -0.363 and -0.305). Clinician-assessed improvement in HF or AF symptoms from diagnosis to 12 months was associated with patient-reported improvement in HRQoL (HFsocial: F(250.2) = 3.11, p < 0.046; HFphysical: F(251.2) = 11.19, p < 0.001; and AF: F(762.2) = 25.86, p < 0.001). When clinicians reported unchanged or worsening symptoms, no significant HRQoL changes were reported by patients.

Conclusion: Clinician-assessed symptoms correlate moderately with patient-reported HRQoL, with large inter-individual variation in HRQoL. NYHA and EHRA classifications may not accurately reflect patient-perceived burden of disease over time. Incorporating patient-reported outcomes into routine care may better guide treatment, improve the identification of patients' needs, and support informed clinical and shared decision-making.

临床评估的NYHA和EHRA症状分类仅能适度反映心衰和房颤患者报告的生活质量。
背景:临床医生评估的症状应与患者感知的症状一致。然而,患者对症状对健康相关生活质量(HRQoL)影响的评价可能与临床医生不同。本研究旨在评估心力衰竭(HF)和心房颤动(AF)患者患者感知的HRQoL与临床评估的症状严重程度之间的关系。方法:前瞻性纳入新诊断的HF和AF患者。在诊断时和12个月后的常规心衰和房颤门诊就诊期间收集症状和HRQoL信息。临床医生使用NYHA分级评估HF症状严重程度,使用EHRA评分评估AF症状严重程度。使用CaReQol-CHF (HF)和AFEQT (AF)评估HRQoL。结果:254例心衰患者和765例房颤患者获得了完整的基线和12个月随访信息。NYHA分级与诊断和随访时的CaReQoL-CHF呈正相关(Spearman ρ: HFsocial分别为0.202和0.426,HFphysical分别为0.317和0.421),EHRA评分与AFEQT呈正相关(Spearman ρ: -0.363和-0.305)。临床评估的HF或AF症状从诊断到12个月的改善与患者报告的HRQoL改善相关(HFsocial: F(250.2) = 3.11,p physical: F(251.2) = 11.19,p )结论:临床评估的症状与患者报告的HRQoL中度相关,HRQoL个体间差异较大。NYHA和EHRA分类可能不能准确地反映患者随时间的疾病负担。将患者报告的结果纳入常规护理可以更好地指导治疗,改善对患者需求的识别,并支持知情的临床和共同决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Netherlands Heart Journal
Netherlands Heart Journal CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.70
自引率
5.00%
发文量
84
审稿时长
6-12 weeks
期刊介绍: The scope of the Netherlands Heart Journal is to contribute to the national and international literature by publishing scientific papers in the field of cardiovascular medicine. It also provides a platform for Continuing Medical Education for cardiologists and those in training for the speciality of cardiology in the Netherlands. The Netherlands Heart Journal is made available to cardiologists, cardiologists in training, cardiopulmonary surgeons, cardiopulmonary surgeons in training, internists and paediatric cardiologists. The journal is the official journal of the Netherlands Society of Cardiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书